...
【24h】

Major amputation for intractable extremity melanoma after failure of isolated limb perfusion.

机译:孤立性肢体灌注失败后的顽固性肢端黑色素瘤的大截肢术。

获取原文
获取原文并翻译 | 示例

摘要

AIM: The aim of this study was to analyse indications and results of amputation for intractable extremity melanoma after failure of isolated limb perfusion (ILP). METHODS: Between 1978 and 2001, 451 patients with loco-regional advanced extremity melanoma underwent 505 ILPs. Amputation of the affected extremity had to be carried out for intractable recurrent disease in 11 of these patients. RESULTS: The indications for amputation were uncontrollable pain (n=2), extensive loco-regional tumour progression (n=4), loss of ankle function due to local tumour growth (n=1), and ulcerating and fungating lesions, not responding to other treatments (n=4). Four patients developed stump recurrence after amputation. Ten patients died of melanoma metastases after a median of 11 months (range 2-110 months). Two patients survived more than 5 years after amputation. CONCLUSIONS: Major amputation is rarely indicated for intractable extremity melanoma but long-term survival can be achieved in selected patients.
机译:目的:本研究的目的是分析孤立性肢体灌注(ILP)失败后难治性肢体黑色素瘤截肢的适应症和结果。方法:在1978年至2001年之间,对451例局部区域晚期四肢黑色素瘤患者进行了505次ILP。这些患者中有11例因难治的复发性疾病而必须切除患肢。结果:截肢的指征是无法控制的疼痛(n = 2),局部区域广泛的肿瘤进展(n = 4),由于局部肿瘤生长导致的踝关节功能丧失(n = 1)以及溃疡和真菌性病变,无反应其他治疗(n = 4)。截肢后有四名患者发生残端复发。中位11个月(2-110个月)后,有10名患者死于黑色素瘤转移。截肢后有2名患者存活超过5年。结论:难于截肢的黑色素瘤几乎不建议行大面积截肢术,但是在选定的患者中可以实现长期生存。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号